Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts

Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation

Lancet Neurol.

Latourelle JC, Beste MT, Hadzi TC, Miller RE, Oppenheim JN, Valko MP, Wuest DM, Church BW, Khalil IG, Hayete B, Venuto CS

doi: 10.1016/

Aging and Cognitive Functions

Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease

JAMA Neurol.

Paul KC, Schulz J, Bronstein JM, Lill CM, Ritz BR

doi: 10.1001/jamaneurol.

COMMENTED

Alzheimer’s DiseaseDementia

Office-Based Screening for Dementia in Parkinson Disease: The Montreal Parkinson Risk of Dementia Scale in 4 Longitudinal Cohorts

JAMA Neurol.

Dawson BK, Fereshtehnejad SM, Anang JBM, Nomura T, Rios-Romenets S, Nakashima K, Gagnon JF, Postuma RB

doi: 10.1001/

Aging and Cognitive Functions

REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease

Neurology.

Pagano G, De Micco R, Yousaf T, Wilson H, Chandra A, Politis M

doi: 10.1212/

Aging and Cognitive Functions

Step length predicts executive dysfunction in Parkinson's disease: a 3-year prospective study

J Neurol.

Amboni M, Iuppariello L, Iavarone A, Fasano A, Palladino R, Rucco R, Picillo M, Lista I, Varriale P, Vitale C, Cesarelli M, Sorrentino G, Barone P

doi: 10.1007/s00415-018-8973-x.

Aging and Cognitive Functions

Predicting first fall in newly diagnosed Parkinson's disease: Insights from a fall-naïve cohort.

Mov Disord.

Lord S, Galna B, Yarnall AJ, Coleman S, Burn D, Rochester L

doi: 10.1002/mds.26742.

Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores

Neurology.

Leehey M, Luo S, Sharma S, Wills AA, Bainbridge JL, Wong PS, Simon DK, Schneider J, Zhang Y, Pérez A, Dhall R, Christine CW, Singer C, Cambi F, Boyd JT

doi: 10.1212/

Parkinson’s Disease

Developing and validating Parkinson's disease subtypes and their motor and cognitive progression

J Neurol Neurosurg Psychiatry.

Lawton M, Ben-Shlomo Y, May MT, Baig F, Barber TR, Klein JC, Swallow DMA, Malek N, Grosset KA, Bajaj N, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, Wood NW, Grosset DG, Hu MTM

doi: 10.1136/jnnp-2018-318337.

Aging and Cognitive FunctionsParkinson’s Disease

Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests

Mov Disord.

Hoogland J, van Wanrooij LL, Boel JA, Goldman JG, Stebbins GT, Dalrymple-Alford JC, Marras C, Adler CH, Junque C, Pedersen KF, Mollenhauer B, Zabetian CP, Eslinger PJ, Lewis SJG, Wu RM, Klein M, Rodriguez-Oroz MC, Cammisuli DM, Barone P, Biundo R, de Bie RMA, Schmand BA, Tröster AI, Burn DJ, Litvan I, Filoteo JV, Geurtsen GJ, Weintraub D, IPMDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”

doi: 10.1002/mds.110.

Related content

Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation

Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease

Office-Based Screening for Dementia in Parkinson Disease: The Montreal Parkinson Risk of Dementia Scale in 4 Longitudinal Cohorts

REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease

Step length predicts executive dysfunction in Parkinson's disease: a 3-year prospective study

Predicting first fall in newly diagnosed Parkinson's disease: Insights from a fall-naïve cohort.

Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores

Developing and validating Parkinson's disease subtypes and their motor and cognitive progression

Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests